How to choose between IL-17 inhibitors and IL-23 inhibitors for psoriasis

被引：0
|
作者：
Amin, Mina [1 ]
Lee, Erica B. [2 ]
Wu, Jashin J. [3 ]
机构：
[1] Kaiser Permanente, Med Ctr, Dept Med, Los Angeles, CA USA
[2] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA
[3] Kaiser Permanente, Med Ctr, Dept Dermatol, Los Angeles, CA 90027 USA
来源：
JOURNAL OF DERMATOLOGICAL TREATMENT | 2019年 / 30卷 / 04期
关键词：
PLAQUE PSORIASIS; DOUBLE-BLIND; PHASE-III; PLACEBO; EFFICACY; SECUKINUMAB; GUSELKUMAB; MODERATE; SAFETY;
D O I：
10.1080/09546634.2018.1510174
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：374 / 375
页数：2
相关论文
共 50 条
  • [21] IL-19 Is a Component of the Pathogenetic IL-23/IL-17 Cascade in Psoriasis
    Witte, Ellen
    Kokolakis, Georgios
    Witte, Katrin
    Philipp, Sandra
    Doecke, Wolf-Dietrich
    Babel, Nina
    Wittig, Bianca M.
    Warszawska, Katarzyna
    Kurek, Agata
    Erdmann-Keding, Magdalena
    Kunz, Stefanie
    Asadullah, Khusru
    Kadin, Marshall E.
    Volk, Hans-Dieter
    Sterry, Wolfram
    Wolk, Kerstin
    Sabat, Robert
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (11) : 2757 - 2767
  • [22] The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review
    Tsiogka, Aikaterini
    Gregoriou, Stamatios
    Stratigos, Alexander
    Soulaidopoulos, Stergios
    Rompoti, Natalia
    Panagakis, Pantelis
    Papoutsaki, Marina
    Kostakis, Panagiotis
    Kontochristopoulos, George
    Tsioufis, Konstantinos
    Campanati, Anna
    Offidani, Annamaria
    Vlachopoulos, Charalambos
    Rigopoulos, Dimitrios
    BIOMEDICINES, 2023, 11 (02)
  • [23] Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study
    Dapavo, Paolo
    Siliquini, Niccolo
    Mastorino, Luca
    Avallone, Gianluca
    Merli, Martina
    Agostini, Andrea
    Cariti, Caterina
    Viola, Riccardo
    Stroppiana, Elena
    Verrone, Anna
    Ortoncelli, Michela
    Quaglino, Pietro
    Ribero, Simone
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 2352 - 2357
  • [24] Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study
    Torres, Tiago
    Puig, Luis
    Vender, Ron
    Lynde, Charles
    Piaserico, Stefano
    Carrascosa, Jose M.
    Gisondi, Paolo
    Dauden, Esteban
    Conrad, Curdin
    Mendes-Bastos, Pedro
    Ferreira, Paulo
    Leite, Luiz
    Lu, Justin D.
    Valerio, J.
    Bruni, M.
    Messina, F.
    Nidegger, A.
    Llamas-Velasco, M.
    del Alcazar, E.
    Mufti, A.
    White, Kyra
    Caldarola, G.
    Teixeira, Laetitia
    Romanelli, Paolo
    Desai, K.
    Gkalpakiotis, Spyridon
    Romanelli, Marco
    Yeung, Jensen
    Nogueira, Miguel
    Chiricozzi, Andrea
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) : 567 - 579
  • [25] Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study
    Tiago Torres
    Luis Puig
    Ron Vender
    Charles Lynde
    Stefano Piaserico
    Jose M. Carrascosa
    Paolo Gisondi
    Esteban Daudén
    Curdin Conrad
    Pedro Mendes-Bastos
    Paulo Ferreira
    Luiz Leite
    Justin D. Lu
    J. Valerio
    M. Bruni
    F. Messina
    A. Nidegger
    M. Llamas-Velasco
    E. del Alcazar
    A. Mufti
    Kyra White
    G. Caldarola
    Laetitia Teixeira
    Paolo Romanelli
    K. Desai
    Spyridon Gkalpakiotis
    Marco Romanelli
    Jensen Yeung
    Miguel Nogueira
    Andrea Chiricozzi
    American Journal of Clinical Dermatology, 2021, 22 : 567 - 579
  • [26] IL-23 inhibitors for moderate-to-severe psoriasis
    Ibler, Erin
    Gordon, Kenneth B.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2018, 37 (03) : 158 - 162
  • [27] IL-23 Versus IL-17 in the Pathogenesis of Psoriasis: There Is More to the Story Than IL-17A
    Armstrong, April W.
    Read, Charlotte
    Leonardi, Craig L.
    Kircik, Leon H.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2019, 18 (08) : S202 - S208
  • [28] Advancements in Biologic Therapy for Psoriasis: the IL-23 Inhibitors
    Hadeler, Edward
    Mosca, Megan
    Hong, Julie
    Brownstone, Nicholas
    Bhutani, Tina
    Liao, Wilson
    CURRENT DERMATOLOGY REPORTS, 2021, 10 (01) : 6 - 15
  • [29] Advancements in Biologic Therapy for Psoriasis: the IL-23 Inhibitors
    Edward Hadeler
    Megan Mosca
    Julie Hong
    Nicholas Brownstone
    Tina Bhutani
    Wilson Liao
    Current Dermatology Reports, 2021, 10 : 6 - 15
  • [30] IL-23 and IL-17 in ankylosing spondylitis
    Wendling, Daniel
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (11) : 1547 - 1547
12345